Phase II Data From FIT Biotech's HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
7/20/2010 8:50:34 AM
More...
|
Phase II Data from FIT Biotech’s HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
7/19/2010 10:56:20 AM
More...
|
ImmunoVaccine Technologies Inc. (IVT) Partners with FIT Biotech to Advance a Therapeutic HIV Vaccine
5/27/2009 9:00:31 AM
More...
|